Drugs / Propatyl Nitrate
Propatyl Nitrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02315976 | Apr → Dec 2014 | intermediate coronary syndrome | Fundação Educacional Serra dos Órgãos | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Propatyl Nitrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02315976 ↗ |
| Known as | Etrynit | ChEMBL registry synonym — accepted as the source's own label CHEMBL488280 ↗ |
| Known as | ETT-N | ChEMBL registry synonym — accepted as the source's own label CHEMBL488280 ↗ |
| Known as | Propatilnitrato | ChEMBL registry synonym — accepted as the source's own label CHEMBL488280 ↗ |
| Known as | WIN 9317 | ChEMBL registry synonym — accepted as the source's own label CHEMBL488280 ↗ |
| Modality | Small molecule | — CHEMBL488280 ↗ |
| Route | Oral | “Propatyl nitrate 10mg administered orally, three times daily” NCT02315976 ↗ |